PEGylated cerium oxide nanoparticles alleviate osteoarthritis progression by inhibiting chondrocyte ferroptosis and maintaining cartilage homeostasis
Authors:
- 16 January 2026
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1015, 178563
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 45 references indexed in Scilit:
- Mechanisms of chondrocyte regulated cell death in osteoarthritis: Focus on ROS-triggered ferroptosis, parthanatos, and oxeiptosisBiochemical and Biophysical Research Communications, 2024
- Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful agingAgeing Research Reviews, 2023
- Targeting regulated chondrocyte death in osteoarthritis therapyBiochemical Pharmacology, 2023
- Small Ceria Nanoclusters with High ROS Scavenging Activity and Favorable Pharmacokinetic Parameters for the Amelioration of Chronic Kidney DiseaseAdvanced Healthcare Materials, 2023
- The Role of Ferroptosis in the Pathogenesis of OsteoarthritisThe Journal of Membrane Biology, 2023
- Ceria nanoparticles prophylactic used for renal ischemia-reperfusion injury treatment by attenuating oxidative stress and inflammatory responseBiomaterials, 2022
- Ceria Nanoparticles Meet Hepatic Ischemia‐Reperfusion Injury: The Perfect ImperfectionAdvanced Materials, 2019
- Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrinBioMetals, 2018
- ROS/oxidative stress signaling in osteoarthritisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- The pathophysiology of osteoarthritisAging Clinical and Experimental Research, 2003